There is currently no cure for Parkinson’s – a disease that severely impairs the mobility and quality of life for more than 6.3 million people worldwide, including 80,000 Australians.
La Trobe University researchers have developed a world-first diagnostic blood test, which could enable better outcomes and a greater quality of life for people with the condition.
La Trobe’s blood test will help doctors detect with unprecedented reliability the abnormal metabolism of blood cells in people with Parkinson’s, which will allow them to provide treatment options much earlier.
The US-based Michael J. Fox Foundation for Parkinson’s Research and its local funding partner, the Shake It Up Australia Foundation, have granted La Trobe more than $640,000 to further develop the diagnostic blood test.
La Trobe Professor of Microbiology Paul Fisher said the grant “will allow us to extend our study so we can discover new ways to help diagnose and monitor progression of the disease. It is even possible that the blood test could be developed to detect all types of neuro-degenerative disorders, including Alzheimer’s.”
The test could be available to the public in as little as five years if sufficient additional funds can be raised for its rapid development.
Read more here: La Trobe University.